Skip to main content
YSB Inc. logo

YSB Inc. — Investor Relations & Filings

Ticker · 9885 LEI · 655600S0RFW1TQ6MZP78 HKEX Wholesale and retail trade
Open in API
Filings indexed 196 across all filing types
Latest filing 2025-06-11 Transaction in Own Shar…
Country KY Cayman Islands
Listing HKEX 9885

About YSB Inc.

http://www.ysbang.cn

YSB Inc. specializes in the development and operation of a digital pharmaceutical platform designed to connect various stakeholders within the healthcare supply chain outside of traditional hospital settings. The company's core activities involve the wholesale and retail distribution of pharmaceuticals and healthcare products. Key users of the platform include pharmaceutical manufacturers, distributors, vendors, pharmacies, and primary healthcare institutions.

Recent filings

Filing Released Lang Actions
VOLUNTARY ANNOUNCEMENT SHARE REPURCHASE AND INCREASE IN SHAREHOLDING BY EXECUTIVE DIRECTOR
Transaction in Own Shares Classification · 1% confidence The document is a voluntary announcement on Hong Kong Exchanges detailing the company’s on-market share repurchase program (buyback of its own shares) and also reporting an executive director’s personal acquisition of shares. It primarily reports the corporate share repurchase activity, matching the definition of “Transaction in Own Shares (POS)” for share buybacks.
2025-06-11 English
VOLUNTARY ANNOUNCEMENT SHARE REPURCHASE
Transaction in Own Shares Classification · 1% confidence The document is a voluntary announcement detailing the Company’s on-market share repurchase plan and specific transactions (number of shares repurchased, aggregate amount, average price, cancellation of shares). This matches the definition of a "Transaction in Own Shares" report (Code: POS) rather than a share issuance (SHA) or other category. It is not merely a publication notice, nor an earnings release or regulatory filing. Therefore, it is classified as POS.
2025-06-05 English
Next Day Disclosure Return
Transaction in Own Shares Classification · 1% confidence The document is a Hong Kong Exchange "Next Day Disclosure Return" (Form FF305) detailing changes in issued shares, treasury shares, and on-market share repurchases and sales by the issuer. It provides a full repurchase report and treasury share sales in compliance with Main Board and GEM listing rules. This is not a general regulatory update or a capital-raising announcement but a detailed transaction report of the company’s own share buybacks and treasury share changes. Therefore, it falls under Transaction in Own Shares (POS).
2025-06-05 English
VOLUNTARY ANNOUNCEMENT SHARE REPURCHASE AND INCREASE IN SHAREHOLDING BY EXECUTIVE DIRECTOR
Transaction in Own Shares Classification · 1% confidence The document is a voluntary announcement regarding the company’s on-market share repurchase plan (the company repurchased 100,000 shares) and also discloses an executive director’s open-market share acquisition. The corporate share repurchase clearly falls under “Transaction in Own Shares (POS)”. Although there is also director dealing, the primary focus is on the share repurchase plan. It is not an earnings release, regulatory notice of report publication, or other category. Therefore, this is classified as POS.
2025-06-04 English
Next Day Disclosure Return
Transaction in Own Shares Classification · 1% confidence The document is a Next Day Disclosure Return (Form FF305) under the Hong Kong Listing Rules, detailing changes in issued shares (exercise of share options) and repurchases of own shares (buybacks and treasury sales). It is not an earnings release, management change, or regulatory publication notice, but a report of transactions in the company’s own shares. This aligns with the “Transaction in Own Shares” category.
2025-06-04 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 May 2025
Regulatory Filings Classification · 1% confidence The document is a mandatory monthly return (Form FF301) filed with the Hong Kong Stock Exchange under its Listing Rules, detailing movements in authorised share capital, issued shares, treasury shares, share options, and share repurchases. It does not constitute an annual or interim financial report, earnings release, or investor presentation, nor is it a one‐off share issue or capital change notice; rather, it is a recurring regulatory submission. Therefore, it best fits the General Regulatory Filings category.
2025-06-04 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.